118 related articles for article (PubMed ID: 9301459)
1. Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo.
Milross CG; Mason KA; Hunter NR; Terry NH; Patel N; Harada S; Jibu T; Seong J; Milas L
Eur J Cancer; 1997 Jul; 33(8):1299-308. PubMed ID: 9301459
[TBL] [Abstract][Full Text] [Related]
2. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Milas L; Hunter NR; Mason KA; Kurdoglu B; Peters LJ
Cancer Res; 1994 Jul; 54(13):3506-10. PubMed ID: 7912167
[TBL] [Abstract][Full Text] [Related]
4. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction.
Saito Y; Milross CG; Hittelman WN; Li D; Jibu T; Peters LJ; Milas L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):623-31. PubMed ID: 9231689
[TBL] [Abstract][Full Text] [Related]
5. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
Milas L; Hunter NR; Mason KA; Milross CG; Saito Y; Peters LJ
Cancer Res; 1995 Aug; 55(16):3564-8. PubMed ID: 7627965
[TBL] [Abstract][Full Text] [Related]
6. Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse.
Milas L; Hunter N; Mason KA; Milross C; Peters LJ
Acta Oncol; 1995; 34(3):409-12. PubMed ID: 7779432
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel enhances tumor radioresponse in vivo.
Mason KA; Hunter NR; Milas M; Abbruzzese JL; Milas L
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2431-8. PubMed ID: 9815644
[TBL] [Abstract][Full Text] [Related]
8. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel.
Milross CG; Mason KA; Hunter NR; Chung WK; Peters LJ; Milas L
J Natl Cancer Inst; 1996 Sep; 88(18):1308-14. PubMed ID: 8797771
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate.
Li C; Ke S; Wu QP; Tansey W; Hunter N; Buchmiller LM; Milas L; Charnsangavej C; Wallace S
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1119-26. PubMed ID: 11072171
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
Mason K; Staab A; Hunter N; McBride W; Petersen S; Terry N; Milas L
Int J Oncol; 2001 Mar; 18(3):599-606. PubMed ID: 11179493
[TBL] [Abstract][Full Text] [Related]
11. Combination of taxanes with radiation: preclinical studies.
Milas L; Milas MM; Mason KA
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):12-26. PubMed ID: 10210536
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma.
Milas L; Saito Y; Hunter N; Milross CG; Mason KA
Radiother Oncol; 1996 Aug; 40(2):163-70. PubMed ID: 8884971
[TBL] [Abstract][Full Text] [Related]
13. 130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Wiedenmann N; Valdecanas D; Hunter N; Hyde S; Buchholz TA; Milas L; Mason KA
Clin Cancer Res; 2007 Mar; 13(6):1868-74. PubMed ID: 17363543
[TBL] [Abstract][Full Text] [Related]
14. Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa.
Mason KA; Milas L; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1381-9. PubMed ID: 7635778
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.
Milas L; Hunter NR; Kurdoglu B; Mason KA; Meyn RE; Stephens LC; Peters LJ
Cancer Chemother Pharmacol; 1995; 35(4):297-303. PubMed ID: 7828272
[TBL] [Abstract][Full Text] [Related]
16. Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.
Akimoto T; Seong J; Hunter NR; Buchmiller L; Mason K; Milas L
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):413-9. PubMed ID: 10760438
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Suzuki M; Nishimura Y; Kinashi Y; Takagaki M; Hori H; Nagasawa H; Uto Y; Tsuchiya I; Sadahiro S; Murayama C
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1063-72. PubMed ID: 11429234
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines.
Erlich E; McCall AR; Potkul RK; Walter S; Vaughan A
Gynecol Oncol; 1996 Feb; 60(2):251-4. PubMed ID: 8631547
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha.
Seong J; Milross CG; Hunter NR; Shin HC; Milas L
Anticancer Drugs; 1997 Jan; 8(1):80-7. PubMed ID: 9147616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
